Fingerprint
Dive into the research topics of 'Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: A randomised phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically